How Do I Interpret Antiphospholipid IgG and IgM Levels?

Antiphospholipid antibody lab reports can be overwhelming, full of acronyms and numbers. Interpreting them requires understanding which specific tests were run, the amount of antibody found, and whether the results remain positive over time. Most importantly, having positive antibodies on a lab report does not automatically mean you have Antiphospholipid Syndrome (APS). Doctors use medical classification criteria as a framework, which look for both a qualifying clinical event and persistent laboratory evidence ^[1].

The Three Core APS Tests

A comprehensive APS laboratory evaluation typically involves three main tests. The first two count the amount of antibodies in your blood, while the third tests how your blood functions:

• Anticardiolipin (aCL) and Anti-β2-glycoprotein I (anti-β2GPI): These tests use laboratory methods (like ELISA) to detect specific antibodies in your blood serum ^[2]. They are reported by their type (IgG or IgM) and their concentration.
• Lupus Anticoagulant (LA): Despite its name, this is not a test for lupus. Rather than counting antibodies, it is a functional test that measures how long it takes your blood to clot in a test tube (often appearing on reports as “dRVVT” or aPTT) ^[3]. LA results are usually reported as positive or negative, rather than as an IgG or IgM level.

Interpreting Antibody Risk Profiles

For aCL and anti-β2GPI, laboratories test for two classes of antibodies: IgG and IgM ^[2].
While both can be important, your overall clinical risk is not determined by a single test. Instead, doctors look at your complete antibody profile. Being “triple positive” (testing persistently positive for LA, aCL, and anti-β2GPI) is associated with the highest clinical risk ^[4]. Isolated or low-level results generally carry a lower risk, but your personal risk also depends heavily on your medical history, such as prior blood clots or other health conditions ^[4].

Understanding Titers, Units, and Thresholds

The “titer” refers to the concentration of aCL or anti-β2GPI antibodies detected.

• Units: Anticardiolipin is often reported in GPL (for IgG) or MPL (for IgM) units ^[5]. Anti-β2GPI tests use different, assay-specific units ^[6].
• Thresholds and the 99th Percentile: Different medical guidelines use specific cutoffs for research and classification. The traditional guidelines (often called the Sydney criteria) consider an aCL result positive if it is greater than 40 GPL/MPL or above the 99th percentile of a healthy population ^[7]. Newer 2023 classification criteria (for specific testing methods) categorize 40 to 79 units as “medium” and 80 or above as “high” ^{[7] [6]}.

Because laboratories use different chemical kits and equipment, a “40” in one lab might not mean the same thing as a “40” in another ^[8]. There is no universal standard, so you must always interpret your numbers using the specific reference range provided on your individual lab report ^{[5] [8]}.

The 12-Week Rule: Assessing Persistence

A single positive test result does not confirm persistent antibodies. Antiphospholipid antibodies can be temporary, sometimes spiking during acute infections (like viruses) or periods of inflammation ^[9].

Because temporary spikes happen, medical guidelines require repeating the tests at least 12 weeks later ^[1]. If the second test is negative, it means the required persistence has not been demonstrated.

Important Safety Note: Blood thinners (anticoagulants like warfarin, heparin, or DOACs) can severely interfere with Lupus Anticoagulant (LA) testing, causing false-positive or false-negative results ^[10]. Never stop or alter your anticoagulant medication for a blood test without explicit instructions from your prescribing doctor.

Antibodies vs. Clinical Guidelines

Having high or persistent antibodies means you carry them, but an APS diagnosis also requires a qualifying clinical event ^[1]. In standard classification guidelines, these events include:

• An objectively confirmed blood clot (venous, arterial, or small-vessel) ^[11].
• Specific pregnancy complications, such as one or more unexplained fetal deaths at or beyond 10 weeks, premature birth before 34 weeks due to severe preeclampsia or placental insufficiency, or three or more consecutive unexplained miscarriages before 10 weeks ^[12].

These criteria help standardize research, but real-life diagnosis relies on a specialist’s judgment of your entire health history. Do not start, stop, or change aspirin, blood thinners, or other medications based solely on a lab number; always consult your doctor to discuss what your specific results mean for you.